{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:44:18Z","timestamp":1786373058956,"version":"build-2736575974"},"reference-count":40,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,2]]},"abstract":"<jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>The classification of thrombotic microangiopathy has evolved and expanded due to treatment and advances in understanding of the diseases associated with this clinical presentation. The three clinical forms of thrombotic microangiopathy\u2014thrombotic thrombocytopenic purpura (TTP), hemolytic uremic syndrome (HUS), and disseminated intravascular coagulation\u2014encompass a wide range of disorders that can be classified as either primary (idiopathic) or secondary to another identifiable disease or clinical context. Identification of an inhibitor to a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 (ADAMTS13) in the idiopathic and acute forms of TTP, recognition of the absence of ADAMTS13 inhibition in diarrheal HUS, identification of complement abnormalities in atypical HUS, and a better understanding of the role of plasma therapy, rituximab, and eculizumab therapy have all had a major effect on current understanding of the thrombotic microangiopathies. In this Attending Rounds, a patient with a thrombotic microangiopathy is presented, along with discussion highlighting the difficulty of differentiating TTP from HUS and disseminated intravascular coagulation, the need for a prompt diagnosis, and the role for plasma therapy in appropriately selected patients. The discussion attempts to provide a simple clinical approach to the diagnosis, treatment options, and future course of adults and children suffering from a thrombotic microangiopathy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2215\/cjn.07230711","type":"journal-article","created":{"date-parts":[[2011,12,22]],"date-time":"2011-12-22T23:47:06Z","timestamp":1324597626000},"page":"342-347","source":"Crossref","is-referenced-by-count":7,"title":["Attending Rounds"],"prefix":"10.2215","volume":"7","author":[{"given":"William F.","family":"Clark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ainslie","family":"Hildebrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-21-20230811","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ajh.22091","article-title":"Systemic infections mimicking thrombotic thrombocytopenic purpura.","volume":"86","author":"Booth","year":"2011","journal-title":"Am J Hematol"},{"key":"R2-21-20230811","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJM199108083250604","article-title":"Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura.","volume":"325","author":"Rock","year":"1991","journal-title":"N Engl J Med"},{"key":"R3-21-20230811","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1053\/j.ajkd.2008.07.038","article-title":"Interventions for hemolytic uremic syndrome and thrombotic thrombocytopenic purpura: A systematic review of randomized controlled trials.","volume":"53","author":"Michael","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"R4-21-20230811","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1600-0609.2008.01040.x","article-title":"The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome Registry: The Swiss connection.","volume":"80","author":"George","year":"2008","journal-title":"Eur J Haematol"},{"key":"R5-21-20230811","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1128\/JCM.02013-08","article-title":"Rapid and sensitive detection of Shiga toxin-producing Escherichia coli from nonenriched stool specimens by real-time PCR in comparison to enzyme immunoassay and culture.","volume":"47","author":"Grys","year":"2009","journal-title":"J Clin Microbiol"},{"key":"R6-21-20230811","first-page":"1","article-title":"Recommendations for diagnosis of Shiga toxin-producing Escherichia coli infections by clinical laboratories.","volume":"58","author":"Gould","year":"2009","journal-title":"MMWR Recomm Rep"},{"key":"R7-21-20230811","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1365-3148.2006.00720.x","article-title":"A systematic review of randomized controlled trials for plasma exchange in the treatment of thrombotic thrombocytopenic purpura.","volume":"17","author":"Brunskill","year":"2007","journal-title":"Transfus Med"},{"key":"R8-21-20230811","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1053\/j.seminhematol.2003.10.001","article-title":"The Oklahoma Thrombotic Thrombocytopenic Purpura-Hemolytic Uremic Syndrome (TTP-HUS) Registry: A community perspective of patients with clinically diagnosed TTP-HUS.","volume":"41","author":"George","year":"2004","journal-title":"Semin Hematol"},{"key":"R9-21-20230811","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1046\/j.1365-2141.1998.01080.x","article-title":"Laboratory abnormalities in thrombotic thrombocytopenic purpura.","volume":"103","author":"Rock","year":"1998","journal-title":"Br J Haematol"},{"key":"R10-21-20230811","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/j.1537-2995.2004.03422.x","article-title":"Pregnancy outcomes after recovery from thrombotic thrombocytopenic purpura-hemolytic uremic syndrome.","volume":"44","author":"Vesely","year":"2004","journal-title":"Transfusion"},{"key":"R11-21-20230811","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1681\/ASN.2010030308","article-title":"Pulling the trigger in atypical hemolytic uremic syndrome: The role of pregnancy.","volume":"21","author":"Goodship","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R12-21-20230811","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ajog.2008.03.011","article-title":"Thrombotic thrombocytopenic purpura in 166 pregnancies: 1955-2006.","volume":"199","author":"Martin","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"R13-21-20230811","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1136\/ard.2003.007245","article-title":"Thrombotic microangiopathic haemolytic anaemia and antiphospholipid antibodies.","volume":"63","author":"Espinosa","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"R14-21-20230811","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3324\/haematol.10963","article-title":"Pancreatitis preceding acute episodes of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: Report of five patients with a systematic review of published reports.","volume":"92","author":"Swisher","year":"2007","journal-title":"Haematologica"},{"key":"R15-21-20230811","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1634\/theoncologist.12-1-11","article-title":"Disseminated malignancy misdiagnosed as thrombotic thrombocytopenic purpura: A report of 10 patients and a systematic review of published cases.","volume":"12","author":"Francis","year":"2007","journal-title":"Oncologist"},{"key":"R16-21-20230811","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1161\/HYPERTENSIONAHA.107.103127","article-title":"Association between thrombotic microangiopathy and reduced ADAMTS13 activity in malignant hypertension.","volume":"51","author":"van den Born","year":"2008","journal-title":"Hypertension"},{"key":"R17-21-20230811","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1097\/CCO.0b013e3280148a2f","article-title":"Thrombotic microangiopathy following allogeneic hematopoietic stem cell transplantation.","volume":"19","author":"Kojouri","year":"2007","journal-title":"Curr Opin Oncol"},{"key":"R18-21-20230811","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1309\/AJCPPNF63FLIORCI","article-title":"Platelet count and prothrombin time help distinguish thrombotic thrombocytopenic purpura-hemolytic uremic syndrome from disseminated intravascular coagulation in adults.","volume":"133","author":"Park","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"R19-21-20230811","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1182\/blood-2003-01-0193","article-title":"ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: Relation to presenting features and clinical outcomes in a prospective cohort of 142 patients.","volume":"102","author":"Vesely","year":"2003","journal-title":"Blood"},{"key":"R20-21-20230811","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3324\/haematol.11739","article-title":"ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission.","volume":"93","author":"Peyvandi","year":"2008","journal-title":"Haematologica"},{"key":"R21-21-20230811","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJMra0902814","article-title":"Atypical hemolytic-uremic syndrome.","volume":"361","author":"Noris","year":"2009","journal-title":"N Engl J Med"},{"key":"R22-21-20230811","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1038\/ki.2008.621","article-title":"TTP\/HUS: Observational studies generate hypotheses that lead to randomized controlled trials.","volume":"75","author":"Clark","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"R23-21-20230811","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1182\/blood-2010-07-271445","article-title":"How I treat patients with thrombotic thrombocytopenic purpura: 2010.","volume":"116","author":"George","year":"2010","journal-title":"Blood"},{"key":"R24-21-20230811","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1365-2141.2008.07317.x","article-title":"Treating TTP\/HUS with plasma exchange: A single centre\u2019s 25-year experience.","volume":"143","author":"Forzley","year":"2008","journal-title":"Br J Haematol"},{"key":"R25-21-20230811","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2141.2006.06448.x","article-title":"Remission in acute refractory and relapsing thrombotic thrombocytopenic purpura following rituximab is associated with a reduction in IgG antibodies to ADAMTS-13.","volume":"136","author":"Scully","year":"2007","journal-title":"Br J Haematol"},{"key":"R26-21-20230811","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.transci.2010.09.018","article-title":"Sanz MA on behalf of the Grupo Espanol de Aferesis (GEA): Efficacy and safety of rituximab in adult patients with idiopathic relapsing or refractory thrombotic thrombocytopenic purpura: Results of a Spanish multicenter study.","volume":"43","author":"De la Rubia","year":"2010","journal-title":"Transfus Apheresis Sci"},{"key":"R27-21-20230811","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/jca.20091","article-title":"Rituximab therapy for thrombotic thrombocytopenic purpura: A proposed study of the Transfusion Medicine\/Hemostasis Clinical Trials Network with a systematic review of rituximab therapy for immune-mediated disorders.","volume":"21","author":"George","year":"2006","journal-title":"J Clin Apher"},{"key":"R28-21-20230811","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1365-2141.2010.08091.x","article-title":"Long-term, sub-clinical cardiac and renal complications in patients with multiple relapses of thrombotic thrombocytopenic purpura.","volume":"149","author":"Viswanathan","year":"2010","journal-title":"Br J Haematol"},{"key":"R29-21-20230811","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1537-2995.2008.01938.x","article-title":"Long-term deficits in health-related quality of life after recovery from thrombotic thrombocytopenic purpura.","volume":"49","author":"Lewis","year":"2009","journal-title":"Transfusion"},{"key":"R30-21-20230811","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1001\/jama.290.10.1360","article-title":"Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: A systematic review, meta-analysis, and meta-regression.","volume":"290","author":"Garg","year":"2003","journal-title":"JAMA"},{"key":"R31-21-20230811","doi-asserted-by":"crossref","first-page":"c6020","DOI":"10.1136\/bmj.c6020","article-title":"Long term risk for hypertension, renal impairment, and cardiovascular disease after gastroenteritis from drinking water contaminated with Escherichia coli O157:H7: A prospective cohort study.","volume":"341","author":"Clark","year":"2010","journal-title":"BMJ"},{"key":"R32-21-20230811","doi-asserted-by":"crossref","first-page":"e673","DOI":"10.1542\/peds.2004-2236","article-title":"Relative nephroprotection during Escherichia coli O157:H7 infections: Association with intravenous volume expansion.","volume":"115","author":"Ake","year":"2005","journal-title":"Pediatrics"},{"key":"R33-21-20230811","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1056\/NEJMc1100859","article-title":"Eculizumab in severe Shiga-toxin-associated HUS.","volume":"364","author":"Lapeyraque","year":"2011","journal-title":"N Engl J Med"},{"key":"R34-21-20230811","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1016\/S0140-6736(11)61253-1","article-title":"Treatment of severe neurological deficits with IgG depletion through immunoadsorption in patients with Escherichia coli O104:H4-associated haemolytic uraemic syndrome: A prospective trial.","volume":"378","author":"Greinacher","year":"2011","journal-title":"Lancet"},{"key":"R35-21-20230811","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/S0140-6736(11)61145-8","article-title":"Management of an acute outbreak of diarrhoea-associated haemolytic uraemic syndrome with early plasma exchange in adults from southern Denmark: An observational study.","volume":"378","author":"Colic","year":"2011","journal-title":"Lancet"},{"key":"R36-21-20230811","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1046\/j.1365-2141.2003.04049.x","article-title":"Guidelines on the diagnosis and management of the thrombotic microangiopathic haemolytic anaemias.","volume":"120","author":"Allford","year":"2003","journal-title":"Br J Haematol"},{"key":"R37-21-20230811","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/(SICI)1098-1101(1998)13:1<16::AID-JCA3>3.0.CO;2-C","article-title":"Cellular source of serum lactate dehydrogenase elevation in patients with thrombotic thrombocytopenic purpura.","volume":"13","author":"Cohen","year":"1998","journal-title":"J Clin Apher"},{"key":"R38-21-20230811","doi-asserted-by":"crossref","first-page":"414","DOI":"10.5414\/CNP57414","article-title":"The LDH ratio as a marker for response to plasma exchange in HUS\/TTP of the adult.","volume":"57","author":"Haas","year":"2002","journal-title":"Clin Nephrol"},{"key":"R39-21-20230811","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1111\/j.1537-2995.2008.02082.x","article-title":"Clinical outcomes after platelet transfusions in patients with thrombotic thrombocytopenic purpura.","volume":"49","author":"Swisher","year":"2009","journal-title":"Transfusion"},{"key":"R40-21-20230811","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1291\/hypres.28.89","article-title":"Thrombotic microangiopathy in malignant hypertension and hemolytic uremic syndrome (HUS)\/thrombotic thrombocytopenic purpura (TTP): Can we differentiate one from the other?","volume":"28","author":"Shibagaki","year":"2005","journal-title":"Hypertens Res"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201202000-00021","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:41:41Z","timestamp":1786369301000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201202000-00021"}},"subtitle":["Microangiopathic Hemolytic Anemia with Renal Insufficiency"],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.07230711","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}